Sharon Bio-Medicine resumes operations
Operations of Line II was stopped due to a fire incident earlier
Operations of Line II was stopped due to a fire incident earlier
Oscotec has successfully completed phase 2 study in patients with chronic ITP last year
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Pharma Solutions operates 10 research and development and/or production sites globally
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
The pilot plant is focused on scaling up beverage production and will support applications
To accelerate the development of next-generation radioconjugates to treat cancer
Subscribe To Our Newsletter & Stay Updated